Vetter, a global leader in prefilled drug delivery systems, was paid a special visit today at its Ravensburg, Germany facilities by Illinois governor, Bruce Rauner.
The governor was accompanied by a delegation of approximately 20 key state and county representatives, including notable Illinois economic institutions and organisations.
Together with Vetter management, the contingent discussed present local and global economic issues affecting manufacturing and trade.
The delegation was also given a guided tour of one of the company’s aseptic production sites and its centre for visual inspection and logistics.
“I enjoyed meeting members of the Vetter team and touring their high-quality pharmaceutical manufacturing facility here in the beautiful town of Ravensburg,” said Governor Rauner.
“It was exciting to hear about their history and their growth plans for the future. Vetter is an important Illinois corporate citizen and we look forward to supporting their continued success in our state.”
“It is a distinct honour that the governor of Illinois paid a special visit to our German headquarters,” said Udo J. Vetter, Chairman of the company’s Advisory Board and member of the owner family.
“This visit by such a prestigious delegation of individuals is another confirmation of the successful work and contribution we are making to the US life science industry.”
“Having the opportunity to discuss the current economic environment is of central importance for future initiatives,” added Peter Soelkner, one of the three Vetter Managing Directors involved in the gubernatorial meeting.
“Also, the opportunity to better understand our individual positions and thoughts as trading partners from both sides of the Atlantic was most beneficial.”
During the course of the visit, Vetter outlined the status of its site for injectable development services in Skokie. The current 37,000 sq. ft facility at the Illinois Science+Technology Park is presently undergoing a further expansion of more than 12,000 sq. ft, which includes storage areas as well as office space.
This expansion is a result of the continuous increase in customer demand and an increase in project work within the early clinical development of injectables.
In addition, Vetter reviewed its future plans for the company’s Des Plaines property. The pharmaceutical service provider completed the purchase of the 18-acre site in Des Plaines in 2017 as an integral part of the company’s ‘one stop shopping’ initiative, enabling a fast project start-up upon completion of co-operation agreements with customers.
Initial renovations at the site are complete. Most recently, office space for Vetter’s US Key Account Management, Human Resources and Legal departments was equipped and is now ready for use.
